Legacy Receives New York State CLEP Approval for Two Laboratory-Developed Tests: Semen Analysis and DNA Fragmentation

Legacy clears New York's stringent pre-market review of laboratory-developed tests for both of its core andrology assays, semen analysis and DNA fragmentation analysis. NEW YORK, June 24, 2026 /PRNewswire/ -- Legacy, a leading male fertility testing and sperm preservation company, today...